BARDA BID 2021 Logo
BARDA INDUSTRY DAY
November 3-4, 2021     Virtual Event

Strengthening Partnerships, Advancing Innovation

Thank you for attending. We value your feedback.
Check back for videos and other post-conference updates.

TAKE OUR SURVEY!
WHAT IS BARDA INDUSTRY DAY?

BARDA Industry Day is our annual conference, held to increase awareness of U.S. government medical countermeasure priorities, interact with BARDA and ASPR staff, and network with public and private sector colleagues working in the health security space. During BARDA Industry Day 2020, the one-day virtual event attracted 1300+ attendees, featured BARDA program goals and funding updates, expert presentations from government and industry partners, 13 interactive breakout sessions, and two Lightning Talk sessions showcasing 20 exciting technologies.

Read More
icon multiple people Multiple Networking Opportunities
icon of star Priorities
icon hands shaking Industry Partners
icon of light bulb Innovation
icon of door wiht arrow Industry & Government Access
icon of fire shaped message cloud Fireside Chat
icon of person at podium

Our Featured Speakers

Follow us on social media or sign-up for email updates to stay informed when we announcement our speakers!

Dawn O'Connell
Dawn O'Connell, JD

Assistant Secretary for Preparedness & Response
U.S. Department of Health & Human Services

Marcella Nunez-Smith, MD, MHS.
Marcella Nunez-Smith, MD, MHS

Chair
Presidential COVID-19 Health Equity Task Force

Matteo Lai
Matteo Lai, MSc, MS

Co-Founder and CEO
Empatica

Stéphane Bancel
Stéphane Bancel, MS, MBA

Chief Executive Officer
Moderna

Jason W. Roos, PhD
Jason W. Roos, PhD

Joint Program Executive Officer for
Chemical, Biological, Radiological & Nuclear Defense

Gary L. Disbrow
Gary L. Disbrow, PhD

Director, BARDA
U.S. Department of Health & Human Services

Kathleen Neuzil
Kathleen Neuzil, MD, MPH, FIDSA

Director of the Center for Vaccine
Development and Global Health
University of Maryland School of Medicine

Trevor Mundel
Trevor Mundel, MD, PhD

President, Global Health Division
Bill & Melinda Gates Foundation

icon calendar

EVENT AGENDA

Check back for agenda details and updates. We plan to feature a robust lineup of speakers ranging from industry experts to BARDA’s annual division updates. This year’s topics will focus on our 2021 theme, “Strengthening Partnerships, Advancing Innovation” and feature presentations and discussions about our ongoing collaborative partnerships. Our Division Directors will provide a detailed look back on their annual accomplishments, as well as sharing our expected goals and partnership opportunities for the upcoming year. BARDA Director, Dr. Gary Disbrow will give the 2021 Director’s Update, and our keynote speaker and panel discussions will round out this year’s agenda along with our Lightning Talks.

DAY 1 | November 3, 2021 VIRTUAL EVENT
MORNING PLENARY SESSION | 10:00 AM – 12:15 PM
10:00 AM BARDA WELCOME – Linda Lambert, PhD
Deputy Director, Biomedical Advanced Research and Development Authority and Director, Medical Countermeasures Program Support Services
10:00 AM – 10:10 AM ASPR WELCOME! – Dawn O'Connell, JD
Assistant Secretary for Preparedness and Response
10:10 AM – 10:20 AM GOVERNMENT PARTNER – Marcella Nunez-Smith, MD, MHS
Chair, Presidential COVID-19 Health Equity Task Force
10:20 AM – 10:30 AM GOVERNMENT PARTNER - Jason Roos, PhD
Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRN)
10:30 AM – 10:40 AM INDUSTRY PARTNER – Matteo Lai, MSc, MS
Co-founder and Chief Executive Officer of Empatica
10:40 AM – 10:50 AM INDUSTRY PARTNER - Stephane Bancel, MS, MBA
Chief Executive Officer of Moderna, Inc
10:50 AM – 11:20 AM BARDA DIRECTOR’S UPDATE - Gary Disbrow, PhD
Director, Biomedical Advanced Research and Development Authority (BARDA)
PROGRAM OVERVIEWS
Chemical, Biological, Radiological and Nuclear (CBRN)
Chris Houchens, PhD, Director
Division of Research, Innovation, and Ventures (DRIVe)
Sandeep Patel, PhD, Director
Influenza and Emerging Infectious Diseases (IEID)
Ruben Donis, PhD, (Acting) Director
Contract Management & Acquisition (CMA)
Matthew McCord, JD, Chief Contracting Officer
LUNCH BREAK
BREAKOUT SESSION I | 1:00 PM – 2:00 PM
Track 1 Chemical, Biological, Radiological and Nuclear Divisional Breakout
  • Vaccines Program
  • Antivirals & Antitoxins Program
  • Antibacterials Program
  • Track 2 Division of Research, Innovation, and Ventures Divisional Breakout (LIVE)
    Track 3 Regulatory and Quality Affairs Divisional Breakout
    BREAKOUT SESSION II | 2:00 PM – 3:00 PM
    Track 1 Influenza and Emerging Infectious Diseases Divisional Breakout
    Track 2 Introduction to BARDA Ventures & Global Health Investment Corporation Breakout (LIVE)
    Track 3 MCM Procurement Under PBS Contracts: Regulatory and Quality Affairs Considerations Breakout
    15 MINUTE BREAK
    BREAKOUT SESSION III | 3:15 PM – 4:15 PM
    Track 1 Lightning Talks 1
    Track 2 Early-Stage Product Development Simulation Breakout
    Track 3 Leveraging Experience with Pandemic Influenza Vaccines for Emerging Infectious Disease Preparedness
    GLOBAL PANDEMIC DISCUSSION 4:15 PM - 5:15 PM
    Preparing for the Next Pandemic Starting Now (LIVE)
    CLOSING | 5:15 PM Gary Disbrow, PhD
    PM Networking
    5:15 PM – 6:15 PM PM Networking (join a session)
    DAY 2 | November 4, 2021 VIRTUAL EVENT
    AM NETWORKING
    9:00 AM – 10:00 AM AM Networking (join a session)
    MORNING PLENARY SESSION 10:00 AM – 11:30 AM
    10:00 am – 10:05 am WELCOME BACK! – Linda Lambert, PhD
    Deputy Director, Biomedical Advanced Research and Development Authority (BARDA) Director, Medical Countermeasures Program Support Services
    10:05 am – 10:35 am KEYNOTE SPEAKER – Trevor Mundel, MD
    President, Global Health Division, Bill & Melinda Gates Foundation
    10:35 am – 10:45 am HIGHLIGHTED SPEAKER – Kathleen Neuzil, MD, MPH, FIDSA
    Director of the Center for Vaccine Development and Global Health
    University of Maryland School of Medicine
    10:45 am – 11:15 am FIRESIDE CHAT - Dawn O'Connell, JD Assistant Secretary for Preparedness and Response and
    Dr. Gary Disbrow, BARDA Director
    PROGRAM OVERVIEWS
    Detection, Diagnostics, & Devices Infrastructure (DDDI)
    Rodney Wallace, Director
    Division of Clinical Development (DCD)
    Rich Gorman, MD (Acting) Director
    Division of Nonclinical Development (NCD)
    April Brys, PhD, Director
    Pharmaceutical Countermeasure Infrastructure (PCI)
    Michael Angelastro, Director
    LUNCH BREAK
    BREAKOUT SESSION I 12:30 PM – 1:30 PM
    Track 1 Chemical, Biological, Radiological and Nuclear Divisional Breakout
  • Burn & Blast Medical Countermeasures
  • Radiological & Nuclear Countermeasures Program
  • Chemical Medical Countermeasures
  • Track 2 Impact of the COVID-19 Pandemic on Future Clinical Trials and the BARDA Clinical Studies Network Breakout
    Track 3 Pharmaceutical Countermeasures Infrastructure (PCI) Divisional Breakout
    BREAKOUT SESSION II | 1:30 PM – 2:30 PM
    Track 1 Detection, Diagnostics, & Devices Infrastructure (DDDI) Divisional Breakout
    Track 2 Leveraging Nonclinical Partnerships To Address Critical and Emerging Threats Breakout
    Track 3 On Demand Manufacturing Breakout
    15 MINUTE BREAK
    BREAKOUT SESSION III | 2:45 PM – 3:45 PM
    Track 1 Therapeutic Development for ARDS Breakout
    Track 2 Repurposing Drugs in Response to Chemical Threats (ReDIRECT) Program Breakout
    Track 3 (No Session Scheduled)
    BREAKOUT SESSION IV | 3:45 PM – 4:45 PM
    Track 1 Lightning Talks II
    Track 2 Next Generation Nonclinical Tools for Advancing Medical Countermeasure Development Breakout
    Track 3 BARDA Partnership with JPEO-CBRN
    CLOSING | 4:45 PM Gary Disbrow, PhD
    PM Networking
    4:45 PM – 5:45 PM PM Networking (join a session)
    LIGHTNING TALKS
    SHOWCASING INNOVATIVE DISCOVERIES AND NETWORKING
    BID 2021 SELECTEES
    BARDA Industry Day

    GET BID 2021 EMAIL UPDATES

    To receive updates about BARDA Industry Day and other news, enter your email address.

    CONNECT WITH US

    PRESENTED BY
    HHS, ASPR BARDA Logos
    \
    Website Refresh - www.medicalcountermeasures.gov is pleased to announce a phased launch of our newly redesigned public website. We are making website improvements to provide a more modern and customer-centric web experience. Over the next several months you will see differences throughout the site while we continue implementing updates. Thank you for your understanding and please let us know if you have any questions: techwatchinbox@hhs.gov